Induced Pluripotent Stem Cells (iPSCs) Market in United States, United Kingdom – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

Induced Pluripotent Stem Cells (iPSCs) Market – Report Overview

Pacific Business Consulting’s “Induced Pluripotent Stem Cells (iPSCs) Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Induced Pluripotent Stem Cells (iPSCs) market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the Induced Pluripotent Stem Cells (iPSCs) market exceeded a valuation of over US$ 1.6 Billion, and it is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 8.0% from 2023 to 2030. The market is expected to potentially surpass US$ 3.0 Billion by 2030.

The market for induced pluripotent stem cells (iPSCs) is experiencing growth driven by factors such as increased usage in stem cell therapies, a growing biotechnology industry, better investment opportunities, and a rise in chronic diseases. iPSCs are developed from cells transformed into an embryonic-like pluripotent state, offering a versatile source for various human cells needed in therapeutic applications. Their distinct features open up a wide range of applications in biopharmaceuticals, toxicological testing, disease modeling, and high-throughput screening.

The prevalence of personalized medicines for various disease treatments is also contributing to the accelerated adoption of iPSCs in developing therapies. These cells, generated from individuals with different genetic disorders, provide valuable resources for developing individualized models of psychiatric diseases and discovering biomarkers for personalized treatment options.

Companies are increasingly focusing on iPSCs in research and development, forming collaborations, and adopting various business strategies. These initiatives are expected to boost the utilization and production of iPSCs in clinical research, leading to market growth. For example, agreements and collaborations between companies such as FUJIFILM Cellular Dynamics, Century Therapeutics, Bristol Myers Squibb, Ncardia, and Kiniciti highlight the growing interest in iPSCs for therapeutic development.

However, challenges such as the lack of awareness about stem cell therapies and the high cost of treatment may hinder market growth. Despite these challenges, the iPSC market is anticipated to grow over the forecast period due to increasing research studies, the use of iPSCs in regenerative medicine, and government funding to promote stem cell-based therapies. The regenerative medicine segment, in particular, is expected to witness significant growth, driven by iPSCs’ adoption in research and therapeutic development for various diseases.

Leading players in the Induced Pluripotent Stem Cells (iPSCs) segment, including Axol Bioscience Ltd., Cynata Therapeutics Limited, Evotec SE, FUJIFILM Cellular Dynamics, Inc., Ncardia, Pluricell Biotech, STEMCELL Technologies Inc., Cellular Engineering Technologies Inc., REPROCELL Inc., and Takara Bio, Inc., are expected to play a crucial role in shaping the future landscape of Induced Pluripotent Stem Cells (iPSCs) technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Induced Pluripotent Stem Cells (iPSCs) market. It also delves into the analysis of present and prospective market competition within the global Induced Pluripotent Stem Cells (iPSCs) market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Induced Pluripotent Stem Cells (iPSCs) market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Induced Pluripotent Stem Cells (iPSCs) market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: Induced Pluripotent Stem Cells (iPSCs)
   • Global Market Outlook: Induced Pluripotent Stem Cells (iPSCs)
2. Competitive Intelligence Analysis: Induced Pluripotent Stem Cells (iPSCs)
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Induced Pluripotent Stem Cells (iPSCs)
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Induced Pluripotent Stem Cells (iPSCs)
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Induced Pluripotent Stem Cells (iPSCs): Ten Major Market (10MM) – Market Analysis, By Derived Cell Type
   • Hepatocytes
   • Fibroblasts
   • Keratinocytes
   • Amniotic Cells
   • Others
9. Induced Pluripotent Stem Cells (iPSCs): Ten Major Market (10MM) – Market Analysis, By Application
   • Drug Development
   • Toxicology Research
   • Tissue Engineering & Regenerative Medicine
   • Disease Modelling
   • Others
10. Induced Pluripotent Stem Cells (iPSCs): Ten Major Market (10MM) – Market Analysis, By End User
    • Academic & Research Centers
    • Pharmaceutical & Biotechnology Companies
    • Other End Users
11. Induced Pluripotent Stem Cells (iPSCs): Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Derived Cell Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Derived Cell Type
      • By Application
      • By End User

12. S. Induced Pluripotent Stem Cells (iPSCs) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Derived Cell Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Derived Cell Type
      • By Application
      • By End User

13. K. Induced Pluripotent Stem Cells (iPSCs) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Derived Cell Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Derived Cell Type
      • By Application
      • By End User

14. Germany Induced Pluripotent Stem Cells (iPSCs) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Derived Cell Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Derived Cell Type
      • By Application
      • By End User

15. France Induced Pluripotent Stem Cells (iPSCs) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Derived Cell Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Derived Cell Type
      • By Application
      • By End User

16. Italy Induced Pluripotent Stem Cells (iPSCs) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Derived Cell Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Derived Cell Type
      • By Application
      • By End User

17. Spain Induced Pluripotent Stem Cells (iPSCs) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Derived Cell Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Derived Cell Type
      • By Application
      • By End User

18. Japan Induced Pluripotent Stem Cells (iPSCs) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Derived Cell Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Derived Cell Type
      • By Application
      • By End User

19. China Induced Pluripotent Stem Cells (iPSCs) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Derived Cell Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Derived Cell Type
      • By Application
      • By End User

20. Australia Induced Pluripotent Stem Cells (iPSCs) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Derived Cell Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Derived Cell Type
      • By Application
      • By End User

21. India Induced Pluripotent Stem Cells (iPSCs) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Derived Cell Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Derived Cell Type
      • By Application
      • By End User

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer